Related Experiment Video

Updated: Jun 13, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Genetics of medulloblastoma: clues for novel therapies

Sara Onvani1, Arnold B Etame, Christian A Smith

  • 1The Hospital for Sick Children, Ontario, Canada.

Expert Review of Neurotherapeutics
|April 28, 2010
PubMed

Insights

Medulloblastoma, a common childhood brain tumor, has limited survival rates and significant treatment side effects. Understanding its molecular biology is key to developing targeted therapies and improving patient outcomes.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Molecular Biology

Background:

  • Medulloblastoma is the most frequent malignant pediatric brain tumor.
  • Current treatments (surgery, radiation, chemotherapy) yield 5-year survival rates of 40-70% but cause severe long-term sequelae.
  • There is a critical need for improved prognostic markers and targeted therapies.

Purpose of the Study:

  • To review recent advances in medulloblastoma molecular biology and genetics.
  • To discuss signaling pathway alterations, molecular profiling techniques, and subclassification schemes.
  • To highlight novel molecular targets for developing less toxic, personalized therapies.

Main Methods:

  • Review of current literature on medulloblastoma molecular biology and genetics.
  • Discussion of molecular profiling techniques and subclassification studies.
  • Analysis of signaling pathways implicated in medulloblastoma pathogenesis.

Main Results:

  • Advances in molecular biology offer new insights into medulloblastoma tumorigenesis.
  • Molecular subclassification schemes are emerging.
  • Several signaling pathways are implicated in medulloblastoma development.

Conclusions:

  • Further research into medulloblastoma's molecular landscape is essential for improved risk stratification.
  • Identifying novel molecular targets can lead to more effective and less toxic treatment strategies.
  • Personalized therapeutic approaches hold promise for better patient outcomes.

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...